Plus Therapeutics Inc (NASDAQ:PSTV) does about 8.53M shares in volume on a normal day but saw 2230584 shares change hands in the recent trading day. The company now has a market cap of 3.45M USD. Its current market price is $0.59, marking a decrease of -13.67% compared to the previous close of $0.68. The 52 week high reached by this stock is $2.67 whilst the lowest price level in 52 weeks is $0.24.
Plus Therapeutics Inc (PSTV) has a 20-day trading average at $0.9704 and the current price is -78.05% off the 52-week high compared with 144.17% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.1161 and its 200-day simple moving average is $1.4166. If we look at the stock’s price movements over the week, volatility stands at 33.90%, which increases to 41.24% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 40.43 to suggest the stock is neutral.
The consensus objective for the share price is $10.00, suggesting that the stock has a potential upside of 94.1% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 17, 2025 when D. Boral Capital initiated the stock to “Buy” and issued a price target of $9. Maxim Group initiated its price target at $6.
The current price level is -39.61%, -47.50%, and -58.63% away from its SMA20, SMA50, and SMA200 respectively, with the PSTV price moving above the 50-day SMA on current market day. Plus Therapeutics Inc (PSTV) stock is down -53.86% over the week and -51.17% over the past month. Its price is -49.04% year-to-date and -66.89% over the past year.
To reach the target analysts have set, the stock logically needs to grow 94.1 percent from here.
Outstanding shares total 5.90M with insiders holding 2.34% of the shares and institutional holders owning 11.50% of the company’s common stock. The company has a return on equity of -522.50%. The beta has a value of 0.87. Price to sales ratio is 0.60.
